Company comparison
Deep Genomics vs Altair
Radar profile, momentum bars, and stack placement side by side.
Deep Genomics
Not scored
momentum
Altair
Not scored
momentum
Deep Genomics capital
—
Altair capital
—
No radar series.
Momentum head-to-head
Attribute tape
| Field | Deep Genomics | Altair |
|---|---|---|
| Category | Vertical applications | Vertical applications |
| Stack | Layer 9 | Layer 9 |
| HQ | Toronto, Ontario, Canada | Troy, Michigan, United States |
| Founded | 2014 | 1985 |
| Status | Operating | Acquired |
| Funding | — | — |
| Momentum | — | — |
| Summary | Deep Genomics is an AI therapeutics company that applies machine learning to RNA biology to discover and develop genetic medicines for genetically defined diseases. Its AI Workbench platform and BigRNA foundation model identify novel RNA-based therapeutic targets and candidates that traditional methods cannot readily find. | Altair provides industrial software for simulation, high-performance computing (HPC), data analytics, and AI, helping engineers design better products and optimize processes. Originally publicly traded on NASDAQ (ALTR), Altair was acquired by Siemens in 2024 and is now integrated into the Siemens Xcelerator industrial software platform. |
| Who for | Teams evaluating AI vendors in this category. | Teams evaluating AI vendors in this category. |
| Differentiator | Deep Genomics is an AI therapeutics company that applies machine learning to RNA biology to discover and develop genetic medicines for genetically defined diseases. Its AI Workbench platform and BigRNA foundation model identify novel RNA-based therapeutic targets and candidates that traditional methods cannot readily find. | Altair provides industrial software for simulation, high-performance computing (HPC), data analytics, and AI, helping engineers design better products and optimize processes. Originally publicly traded on NASDAQ (ALTR), Altair was acquired by Siemens in 2024 and is now integrated into the Siemens Xcelerator industrial software platform. |
